Skip to main content
. 2015 Mar 15;7(1):13. doi: 10.1186/s13195-015-0094-5

Table 4.

Additional metabolites of interest

Molecule Coupling F2–F1 (ppm) Control mean volume/Cr RBT mean volume/Cr % Diff between mean and RBT Effect size
NAA -CH3 2.00–2.00 1.215 ± 0.101 1.294 ± 0.070 7 ± 10 0.95
tCho (CH3)3-N + −CH2-CH2-OH 3.51-4.05 0.018 ± 0.002 0.020 ± 0.016 11 ± 81 0.23
(CH3)3-N + −CH2-CH2-OH 3.20-3.20 0.726 ± 0.009 0.774 ± 0.052 7 ± 7 1.63
mI -CH(OH)-CH(OH) 3.63–3.29 0.029 ± 0.013 0.032 ± 0.011 10 ± 61 0.26
3.55–3.55 0.342 ± 0.013 0.354 ± 0.029 4 ± 10 0.58

Data are presented as described in Table 3, that is, relative to creatine. In all cases, the differences between control and RBT were not statistically significant.

Abbreviations: mI, myo-inositol; NAA, N-acetyl aspartate; RBT, repetitive brain trauma; tCho, total choline. In bold are the proton groups that give rise to the crosspeak chemical shifts indicated in the third column.